Literature DB >> 29779730

Postthrombotic Syndrome: Long-Term Sequela of Deep Venous Thrombosis.

Abdelmoniem Moustafa1, Hussam Mohammad Alim1, Mohammed Andaleeb Chowdhury2, Ehab A Eltahawy3.   

Abstract

Postthrombotic syndrome is a common long-term complication of proximal lower extremity deep venous thrombosis, which not only significantly affects the quality of life of patients but also imposes a substantial financial burden on our healthcare system. Due to limited awareness and inability of physicians to recognize and treat this condition early, its prevalence is steadily increasing. In this article, we review the pathophysiology, the risk factors involved, diagnostic workup, and the various management options available to treat this condition. Published by Elsevier Inc.

Entities:  

Keywords:  Catheter-directed thrombolysis; Deep venous thrombosis; Postthrombotic syndrome

Mesh:

Year:  2018        PMID: 29779730     DOI: 10.1016/j.amjms.2018.03.004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

1.  Gastrointestinal Malignancies and Venous Thromboembolic Disease: Clinical Significance and Endovascular Interventions.

Authors:  Xin Li; Sasan Partovi; Sameer Gadani; Charles Martin; Avi Beck; Suresh Vedantham
Journal:  Dig Dis Interv       Date:  2020-09-22

Review 2.  Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review.

Authors:  Ke Xuan Li; Gisele Diendéré; Jean-Philippe Galanaud; Nada Mahjoub; Susan R Kahn
Journal:  Res Pract Thromb Haemost       Date:  2021-05-08

3.  Long-Term Association of Venous Thromboembolism With Frailty, Physical Functioning, and Quality of Life: The Atherosclerosis Risk in Communities Study.

Authors:  Pamela L Lutsey; B Gwen Windham; Jeffrey R Misialek; Mary Cushman; Anna Kucharska-Newton; Saonli Basu; Aaron R Folsom
Journal:  J Am Heart Assoc       Date:  2020-06-01       Impact factor: 5.501

4.  Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism.

Authors:  Pamela L Lutsey; Richard F MacLehose; J'Neka S Claxton; Rob F Walker; Terrence J Adam; Alvaro Alonso; Neil A Zakai
Journal:  Vasc Med       Date:  2020-07-27       Impact factor: 3.239

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.